Skip to main content
See every side of every news story
Published loading...Updated

Moderna Stands By UK As Pharma Giants Criticize Pricing - Moderna (NASDAQ:MRNA)

The new centre can produce up to 100 million mRNA vaccine doses annually and supports research into cancer, rare diseases, and immune disorders, strengthening UK health security.

Summary by Benzinga
Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."

6 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in on Wednesday, September 24, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal